866-997-4948(US-Canada Toll Free)

EMEA (Europe,Middle East and Africa) Immunotherapy Market Report 2018

Published By :

QYResearch

Published Date : Jul 2018

Category :

Pharmaceutical

No. of Pages : 100 Pages

In this report, the EMEA Immunotherapy market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Immunotherapy for these regions, from 2013 to 2025 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Immunotherapy market competition by top manufacturers/players, with Immunotherapy sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Abbvie
Amgen, Inc.
Biogen
Bristol-Myers Squibb
Celgene
Johnson & Johnson
Merck
Novartis
Pfizer
Roche

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Monoclonal Antibodies
Therapeutic Vaccines
Checkpoint Inhibitors
Non-Specific Immunotherapy

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Oncology
Inflammation
Central Nervous System
Others

Table of Contents

EMEA (Europe, Middle East and Africa) Immunotherapy Market Report 2018
1 Immunotherapy Overview
1.1 Product Overview and Scope of Immunotherapy
1.2 Classification of Immunotherapy
1.2.1 EMEA Immunotherapy Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 EMEA Immunotherapy Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Monoclonal Antibodies
1.2.4 Therapeutic Vaccines
1.2.5 Checkpoint Inhibitors
1.2.6 Non-Specific Immunotherapy
1.3 EMEA Immunotherapy Market by Application/End Users
1.3.1 EMEA Immunotherapy Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.2 Oncology
1.3.3 Inflammation
1.3.4 Central Nervous System
1.3.5 Others
1.4 EMEA Immunotherapy Market by Region
1.4.1 EMEA Immunotherapy Market Size (Value) Comparison by Region (2013-2025)
1.4.2 Europe Status and Prospect (2013-2025)
1.4.3 Middle East Status and Prospect (2013-2025)
1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Immunotherapy (2013-2025)
1.5.1 EMEA Immunotherapy Sales and Growth Rate (2013-2025)
1.5.2 EMEA Immunotherapy Revenue and Growth Rate (2013-2025)

2 EMEA Immunotherapy Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Immunotherapy Market Competition by Players/Manufacturers
2.1.1 EMEA Immunotherapy Sales Volume and Market Share of Major Players (2013-2018)
2.1.2 EMEA Immunotherapy Revenue and Share by Players (2013-2018)
2.1.3 EMEA Immunotherapy Sale Price by Players (2013-2018)
2.2 EMEA Immunotherapy (Volume and Value) by Type/Product Category
2.2.1 EMEA Immunotherapy Sales and Market Share by Type (2013-2018)
2.2.2 EMEA Immunotherapy Revenue and Market Share by Type (2013-2018)
2.2.3 EMEA Immunotherapy Sale Price by Type (2013-2018)
2.3 EMEA Immunotherapy (Volume) by Application
2.4 EMEA Immunotherapy (Volume and Value) by Region
2.4.1 EMEA Immunotherapy Sales and Market Share by Region (2013-2018)
2.4.2 EMEA Immunotherapy Revenue and Market Share by Region (2013-2018)
2.4.3 EMEA Immunotherapy Sales Price by Region (2013-2018)

3 Europe Immunotherapy (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Immunotherapy Sales and Value (2013-2018)
3.1.1 Europe Immunotherapy Sales Volume and Growth Rate (2013-2018)
3.1.2 Europe Immunotherapy Revenue and Growth Rate (2013-2018)
3.2 Europe Immunotherapy Sales and Market Share by Type
3.3 Europe Immunotherapy Sales and Market Share by Application
3.4 Europe Immunotherapy Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Immunotherapy Sales Volume by Countries (2013-2018)
3.4.2 Europe Immunotherapy Revenue by Countries (2013-2018)
3.4.3 Germany Immunotherapy Sales and Growth Rate (2013-2018)
3.4.4 France Immunotherapy Sales and Growth Rate (2013-2018)
3.4.5 UK Immunotherapy Sales and Growth Rate (2013-2018)
3.4.6 Russia Immunotherapy Sales and Growth Rate (2013-2018)
3.4.7 Italy Immunotherapy Sales and Growth Rate (2013-2018)
3.4.8 Benelux Immunotherapy Sales and Growth Rate (2013-2018)

4 Middle East Immunotherapy (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Immunotherapy Sales and Value (2013-2018)
4.1.1 Middle East Immunotherapy Sales Volume and Growth Rate (2013-2018)
4.1.2 Middle East Immunotherapy Revenue and Growth Rate (2013-2018)
4.2 Middle East Immunotherapy Sales and Market Share by Type
4.3 Middle East Immunotherapy Sales and Market Share by Application
4.4 Middle East Immunotherapy Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Immunotherapy Sales Volume by Countries (2013-2018)
4.4.2 Middle East Immunotherapy Revenue by Countries (2013-2018)
4.4.3 Saudi Arabia Immunotherapy Sales and Growth Rate (2013-2018)
4.4.4 Israel Immunotherapy Sales and Growth Rate (2013-2018)
4.4.5 UAE Immunotherapy Sales and Growth Rate (2013-2018)
4.4.6 Iran Immunotherapy Sales and Growth Rate (2013-2018)

5 Africa Immunotherapy (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Immunotherapy Sales and Value (2013-2018)
5.1.1 Africa Immunotherapy Sales Volume and Growth Rate (2013-2018)
5.1.2 Africa Immunotherapy Revenue and Growth Rate (2013-2018)
5.2 Africa Immunotherapy Sales and Market Share by Type
5.3 Africa Immunotherapy Sales and Market Share by Application
5.4 Africa Immunotherapy Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Immunotherapy Sales Volume by Countries (2013-2018)
5.4.2 Africa Immunotherapy Revenue by Countries (2013-2018)
5.4.3 South Africa Immunotherapy Sales and Growth Rate (2013-2018)
5.4.4 Nigeria Immunotherapy Sales and Growth Rate (2013-2018)
5.4.5 Egypt Immunotherapy Sales and Growth Rate (2013-2018)
5.4.6 Algeria Immunotherapy Sales and Growth Rate (2013-2018)

6 EMEA Immunotherapy Manufacturers/Players Profiles and Sales Data
6.1 Abbvie
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Immunotherapy Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Abbvie Immunotherapy Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Amgen, Inc.
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Immunotherapy Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Amgen, Inc. Immunotherapy Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Biogen
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Immunotherapy Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Biogen Immunotherapy Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Bristol-Myers Squibb
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Immunotherapy Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Bristol-Myers Squibb Immunotherapy Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Celgene
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Immunotherapy Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Celgene Immunotherapy Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Johnson & Johnson
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Immunotherapy Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Johnson & Johnson Immunotherapy Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Merck
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Immunotherapy Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Merck Immunotherapy Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Novartis
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Immunotherapy Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Novartis Immunotherapy Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 Pfizer
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Immunotherapy Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Pfizer Immunotherapy Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 Roche
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Immunotherapy Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Roche Immunotherapy Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview

7 Immunotherapy Manufacturing Cost Analysis
7.1 Immunotherapy Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Immunotherapy

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Immunotherapy Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Immunotherapy Major Manufacturers in 2017
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Immunotherapy Market Forecast (2018-2025)
11.1 EMEA Immunotherapy Sales, Revenue and Price Forecast (2018-2025)
11.1.1 EMEA Immunotherapy Sales and Growth Rate Forecast (2018-2025)
11.1.2 EMEA Immunotherapy Revenue and Growth Rate Forecast (2018-2025)
11.1.3 EMEA Immunotherapy Price and Trend Forecast (2018-2025)
11.2 EMEA Immunotherapy Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Immunotherapy Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Immunotherapy Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Immunotherapy Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Immunotherapy Sales Forecast by Type (2018-2025)
11.7 EMEA Immunotherapy Sales Forecast by Application (2018-2025)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

List of Table

List of Tables and Figures

Figure Product Picture of Immunotherapy
Figure EMEA Immunotherapy Sales Volume (K Units) by Type (2013-2025)
Figure EMEA Immunotherapy Sales Volume Market Share by Type (Product Category) in 2017
Figure Monoclonal Antibodies Product Picture
Figure Therapeutic Vaccines Product Picture
Figure Checkpoint Inhibitors Product Picture
Figure Non-Specific Immunotherapy Product Picture
Figure EMEA Immunotherapy Sales Volume (K Units) by Application (2013-2025)
Figure EMEA Sales Market Share of Immunotherapy by Application in 2017
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Inflammation Examples
Table Key Downstream Customer in Inflammation
Figure Central Nervous System Examples
Table Key Downstream Customer in Central Nervous System
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Immunotherapy Market Size (Million USD) by Region (2013-2025)
Figure Europe Immunotherapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Immunotherapy Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Immunotherapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Immunotherapy Revenue (Million USD) Status and Forecast by Countries
Figure Africa Immunotherapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Immunotherapy Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Immunotherapy Sales Volume and Growth Rate (2013-2025)
Figure EMEA Immunotherapy Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Immunotherapy Market Major Players Product Sales Volume (K Units) (2013-2018)
Table EMEA Immunotherapy Sales Volume (K Units) of Major Players (2013-2018)
Table EMEA Immunotherapy Sales Share by Players (2013-2018)
Figure 2017 Immunotherapy Sales Share by Players
Figure 2017 Immunotherapy Sales Share by Players
Figure EMEA Immunotherapy Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Immunotherapy Revenue (Million USD) by Players (2013-2018)
Table EMEA Immunotherapy Revenue Share by Players (2013-2018)
Table 2017 EMEA Immunotherapy Revenue Share by Players
Table 2017 EMEA Immunotherapy Revenue Share by Players
Table EMEA Immunotherapy Sale Price (USD/Unit) by Players (2013-2018)
Table EMEA Immunotherapy Sales (K Units) and Market Share by Type (2013-2018)
Table EMEA Immunotherapy Sales Share by Type (2013-2018)
Figure Sales Market Share of Immunotherapy by Type (2013-2018)
Figure EMEA Immunotherapy Sales Market Share by Type (2013-2018)
Table EMEA Immunotherapy Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Immunotherapy Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Immunotherapy by Type in 2017
Table EMEA Immunotherapy Sale Price (USD/Unit) by Type (2013-2018)
Table EMEA Immunotherapy Sales (K Units) and Market Share by Application (2013-2018)
Table EMEA Immunotherapy Sales Share by Application (2013-2018)
Figure Sales Market Share of Immunotherapy by Application (2013-2018)
Figure EMEA Immunotherapy Sales Market Share by Application in 2017
Table EMEA Immunotherapy Sales (K Units) and Market Share by Region (2013-2018)
Table EMEA Immunotherapy Sales Share by Region (2013-2018)
Figure Sales Market Share of Immunotherapy by Region (2013-2018)
Figure EMEA Immunotherapy Sales Market Share in 2017
Table EMEA Immunotherapy Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Immunotherapy Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Immunotherapy by Region (2013-2018)
Figure EMEA Immunotherapy Revenue Market Share Regions in 2017
Table EMEA Immunotherapy Sales Price (USD/Unit) by Region (2013-2018)
Figure Europe Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Immunotherapy Revenue and Growth Rate (2013-2018)
Table Europe Immunotherapy Sales (K Units) by Type (2013-2018)
Table Europe Immunotherapy Market Share by Type (2013-2018)
Figure Europe Immunotherapy Market Share by Type in 2017
Table Europe Immunotherapy Sales (K Units) by Application (2013-2018)
Table Europe Immunotherapy Market Share by Application (2013-2018)
Figure Europe Immunotherapy Market Share by Application in 2017
Table Europe Immunotherapy Sales (K Units) by Countries (2013-2018)
Table Europe Immunotherapy Sales Market Share by Countries (2013-2018)
Figure Europe Immunotherapy Sales Market Share by Countries (2013-2018)
Figure Europe Immunotherapy Sales Market Share by Countries in 2017
Table Europe Immunotherapy Revenue (Million USD) by Countries (2013-2018)
Table Europe Immunotherapy Revenue Market Share by Countries (2013-2018)
Figure Europe Immunotherapy Revenue Market Share by Countries (2013-2018)
Figure Europe Immunotherapy Revenue Market Share by Countries in 2017
Figure Germany Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure France Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure UK Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure Russia Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure Italy Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure Benelux Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Immunotherapy Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Immunotherapy Sales (K Units) by Type (2013-2018)
Table Middle East Immunotherapy Market Share by Type (2013-2018)
Figure Middle East Immunotherapy Market Share by Type (2013-2018)
Table Middle East Immunotherapy Sales (K Units) by Applications (2013-2018)
Table Middle East Immunotherapy Market Share by Applications (2013-2018)
Figure Middle East Immunotherapy Sales Market Share by Application in 2017
Table Middle East Immunotherapy Sales Volume (K Units) by Countries (2013-2018)
Table Middle East Immunotherapy Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Immunotherapy Sales Volume Market Share by Countries in 2017
Table Middle East Immunotherapy Revenue (Million USD) by Countries (2013-2018)
Table Middle East Immunotherapy Revenue Market Share by Countries (2013-2018)
Figure Middle East Immunotherapy Revenue Market Share by Countries (2013-2018)
Figure Middle East Immunotherapy Revenue Market Share by Countries in 2017
Figure Saudi Arabia Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure Israel Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure UAE Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure Iran Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Immunotherapy Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Immunotherapy Sales (K Units) by Type (2013-2018)
Table Africa Immunotherapy Sales Market Share by Type (2013-2018)
Figure Africa Immunotherapy Sales Market Share by Type (2013-2018)
Figure Africa Immunotherapy Sales Market Share by Type in 2017
Table Africa Immunotherapy Sales (K Units) by Application (2013-2018)
Table Africa Immunotherapy Sales Market Share by Application (2013-2018)
Figure Africa Immunotherapy Sales Market Share by Application (2013-2018)
Table Africa Immunotherapy Sales Volume (K Units) by Countries (2013-2018)
Table Africa Immunotherapy Sales Market Share by Countries (2013-2018)
Figure Africa Immunotherapy Sales Market Share by Countries (2013-2018)
Figure Africa Immunotherapy Sales Market Share by Countries in 2017
Table Africa Immunotherapy Revenue (Million USD) by Countries (2013-2018)
Table Africa Immunotherapy Revenue Market Share by Countries (2013-2018)
Figure Africa Immunotherapy Revenue Market Share by Countries (2013-2018)
Figure Africa Immunotherapy Revenue Market Share by Countries in 2017
Figure South Africa Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure Nigeria Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure Egypt Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure Algeria Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Table Abbvie Immunotherapy Basic Information List
Table Abbvie Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Abbvie Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure Abbvie Immunotherapy Sales Market Share in EMEA (2013-2018)
Figure Abbvie Immunotherapy Revenue Market Share in EMEA (2013-2018)
Table Amgen, Inc. Immunotherapy Basic Information List
Table Amgen, Inc. Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen, Inc. Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure Amgen, Inc. Immunotherapy Sales Market Share in EMEA (2013-2018)
Figure Amgen, Inc. Immunotherapy Revenue Market Share in EMEA (2013-2018)
Table Biogen Immunotherapy Basic Information List
Table Biogen Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Biogen Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure Biogen Immunotherapy Sales Market Share in EMEA (2013-2018)
Figure Biogen Immunotherapy Revenue Market Share in EMEA (2013-2018)
Table Bristol-Myers Squibb Immunotherapy Basic Information List
Table Bristol-Myers Squibb Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Immunotherapy Sales Market Share in EMEA (2013-2018)
Figure Bristol-Myers Squibb Immunotherapy Revenue Market Share in EMEA (2013-2018)
Table Celgene Immunotherapy Basic Information List
Table Celgene Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Celgene Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure Celgene Immunotherapy Sales Market Share in EMEA (2013-2018)
Figure Celgene Immunotherapy Revenue Market Share in EMEA (2013-2018)
Table Johnson & Johnson Immunotherapy Basic Information List
Table Johnson & Johnson Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure Johnson & Johnson Immunotherapy Sales Market Share in EMEA (2013-2018)
Figure Johnson & Johnson Immunotherapy Revenue Market Share in EMEA (2013-2018)
Table Merck Immunotherapy Basic Information List
Table Merck Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure Merck Immunotherapy Sales Market Share in EMEA (2013-2018)
Figure Merck Immunotherapy Revenue Market Share in EMEA (2013-2018)
Table Novartis Immunotherapy Basic Information List
Table Novartis Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure Novartis Immunotherapy Sales Market Share in EMEA (2013-2018)
Figure Novartis Immunotherapy Revenue Market Share in EMEA (2013-2018)
Table Pfizer Immunotherapy Basic Information List
Table Pfizer Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure Pfizer Immunotherapy Sales Market Share in EMEA (2013-2018)
Figure Pfizer Immunotherapy Revenue Market Share in EMEA (2013-2018)
Table Roche Immunotherapy Basic Information List
Table Roche Immunotherapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Roche Immunotherapy Sales (K Units) and Growth Rate (2013-2018)
Figure Roche Immunotherapy Sales Market Share in EMEA (2013-2018)
Figure Roche Immunotherapy Revenue Market Share in EMEA (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Immunotherapy
Figure Manufacturing Process Analysis of Immunotherapy
Figure Immunotherapy Industrial Chain Analysis
Table Raw Materials Sources of Immunotherapy Major Manufacturers in 2017
Table Major Buyers of Immunotherapy
Table Distributors/Traders List
Figure EMEA Immunotherapy Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure EMEA Immunotherapy Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Immunotherapy Price (USD/Unit) and Trend Forecast (2018-2025)
Table EMEA Immunotherapy Sales (K Units) Forecast by Region (2018-2025)
Figure EMEA Immunotherapy Sales Market Share Forecast by Region (2018-2025)
Table EMEA Immunotherapy Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Immunotherapy Revenue Market Share Forecast by Region (2018-2025)
Table Europe Immunotherapy Sales (K Units) Forecast by Countries (2018-2025)
Figure Europe Immunotherapy Sales Market Share Forecast by Countries (2018-2025)
Table Europe Immunotherapy Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Immunotherapy Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Immunotherapy Sales (K Units) Forecast by Countries (2018-2025)
Figure Middle East Immunotherapy Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Immunotherapy Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Immunotherapy Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Immunotherapy Sales (K Units) Forecast by Countries (2018-2025)
Figure Africa Immunotherapy Sales Market Share Forecast by Countries (2018-2025)
Table Africa Immunotherapy Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Immunotherapy Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Immunotherapy Sales (K Units) Forecast by Type (2018-2025)
Figure EMEA Immunotherapy Sales Market Share Forecast by Type (2018-2025)
Table EMEA Immunotherapy Sales (K Units) Forecast by Application (2018-2025)
Figure EMEA Immunotherapy Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *